COHANCE LIFESCIENCES
Back to Income Statement
|
COHANCE LIFESCIENCES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹487 Cr | ₹300 Cr | ₹41,129 Cr | ₹454 Cr | ₹362 Cr |
What is the latest Consolidated Net Profit of COHANCE LIFESCIENCES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹487 Cr |
| Mar2025 | ₹300 Cr |
| Mar2024 | ₹41,129 Cr |
| Mar2023 | ₹454 Cr |
| Mar2022 | ₹362 Cr |
How is Consolidated Net Profit of COHANCE LIFESCIENCES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹487 Cr | 62.30 | |
| Mar2025 | ₹300 Cr | -99.27 | |
| Mar2024 | ₹41,129 Cr | 8,963.15 | |
| Mar2023 | ₹454 Cr | 25.24 | |
| Mar2022 | ₹362 Cr | - | |
Compare Consolidated Net Profit of peers of COHANCE LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| COHANCE LIFESCIENCES | ₹17,241.9 Cr | 0.4% | 5.9% | -48.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹460,696.0 Cr | 0.5% | -4% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,063.0 Cr | 9.1% | 18.2% | 47.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,515.0 Cr | 3.6% | 3.4% | 36.4% | Stock Analytics | |
| CIPLA | ₹114,554.0 Cr | -1.2% | -3.3% | -10.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,308.6 Cr | -1.4% | 2.9% | -8% | Stock Analytics | |
COHANCE LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| COHANCE LIFESCIENCES | 0.4% |
5.9% |
-48.7% |
| SENSEX | -0.4% |
-0.5% |
-5.8% |
You may also like the below Video Courses